![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
DexCom
DXCM
5
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
US Stock MarketDetailed Quotes
LNTH Lantheus
- 98.510
- -1.650-1.65%
Close Apr 10 16:00 ET
- 99.500
- +0.990+1.00%
Post 17:20 ET
6.76BMarket Cap22.59P/E (TTM)
99.590High93.880Low1.15MVolume97.650Open100.160Pre Close112.48MTurnover1.86%Turnover Ratio22.59P/E (Static)68.61MShares126.89052wk High6.21P/B6.10BFloat Cap59.56452wk Low--Dividend TTM61.95MShs Float126.890Historical High--Div YieldTTM5.70%Amplitude1.760Historical Low97.504Avg Price1Lot Size
Lantheus Stock Forum
Sign in to post a comment
$Lantheus (LNTH.US)$
Lantheus Holdings is a specialty radiopharmaceutical company trading around $80 per share. I am bullish.
Fair Value Estimations
A discounted cash flow (DCF) model values LNTH at $99.48 per share, based on a 10% discount rate and moderating FCF growth.
A reverse DCF suggests the market is pricing in just 7% annual FCF growth, despite historical FCF growth of ~50%.
A relative P/E analysis (15x-20x forward earnings) supports a fair v...
Lantheus Holdings is a specialty radiopharmaceutical company trading around $80 per share. I am bullish.
Fair Value Estimations
A discounted cash flow (DCF) model values LNTH at $99.48 per share, based on a 10% discount rate and moderating FCF growth.
A reverse DCF suggests the market is pricing in just 7% annual FCF growth, despite historical FCF growth of ~50%.
A relative P/E analysis (15x-20x forward earnings) supports a fair v...
2
1
Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting
$Lantheus (LNTH.US)$
Revolutionary Prostate Cancer Detection Breakthrough: Lantheus PYLARIFY Shows Success in Low PSA Patients
Revolutionary Prostate Cancer Detection Breakthrough: Lantheus PYLARIFY Shows Success in Low PSA Patients
$Lantheus (LNTH.US)$ lets go! 🚀🚀🚀🚀
These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio? ![]()
$XPeng (XPEV.US)$ stock rose 15.56%. Shares of Chinese stocks gained following an increase in China's June exports.
$QuantumScape (QS.US)$ stock jumped 64.34% after the company announced it entered into an agreement with Volkswagen $VOLKSWAGEN A G (VWAGY.US)$ 's battery company PowerC...
$XPeng (XPEV.US)$ stock rose 15.56%. Shares of Chinese stocks gained following an increase in China's June exports.
$QuantumScape (QS.US)$ stock jumped 64.34% after the company announced it entered into an agreement with Volkswagen $VOLKSWAGEN A G (VWAGY.US)$ 's battery company PowerC...
2
2
$Lantheus (LNTH.US)$ someone knows something
4
$Lantheus (LNTH.US)$ what happened
1
$Cassava Sciences (SAVA.US)$ : “If they can have something big, that stock triples. If they don’t, I think it drifts down. I like that risk/reward, but understand it’s speculative.”
$Lantheus (LNTH.US)$ : “I think it’s great..Lantheus is terrific.”
$Lantheus (LNTH.US)$ : “I think it’s great..Lantheus is terrific.”
$Lantheus (LNTH.US)$ let’s go baby!
Last week’s PDUFAs:
$BeiGene (BGNE.US)$ : Approved 3/8 🎉
⇒ BRUKINSA + obinutuzumab
⇒ Follicular Lymphoma
⇒ sNDA
⇒ PDUFA date: Mar 2024
$Bristol-Myers Squibb (BMY.US)$ : Approved 3/8 🎉
⇒ Opdivo ® + Cisplatin & Gemcitabine
⇒ Urothelial carcinoma
⇒ sBLA
⇒ PDUFA: 04/05/24
$Vanda Pharmaceuticals (VNDA.US)$ : CRL 3/4 🙁
⇒ HETLIOZ®
⇒ insomnia
⇒ sNDA
⇒ PDUFA: 03/04/24
$Eyenovia (EYEN.US)$ : Approved 3/4 🎉
⇒ Clobetasol propionate ophthalmic susp. 0.05% (APP13007)
⇒ postop eye pa...
$BeiGene (BGNE.US)$ : Approved 3/8 🎉
⇒ BRUKINSA + obinutuzumab
⇒ Follicular Lymphoma
⇒ sNDA
⇒ PDUFA date: Mar 2024
$Bristol-Myers Squibb (BMY.US)$ : Approved 3/8 🎉
⇒ Opdivo ® + Cisplatin & Gemcitabine
⇒ Urothelial carcinoma
⇒ sBLA
⇒ PDUFA: 04/05/24
$Vanda Pharmaceuticals (VNDA.US)$ : CRL 3/4 🙁
⇒ HETLIOZ®
⇒ insomnia
⇒ sNDA
⇒ PDUFA: 03/04/24
$Eyenovia (EYEN.US)$ : Approved 3/4 🎉
⇒ Clobetasol propionate ophthalmic susp. 0.05% (APP13007)
⇒ postop eye pa...
22
2
1
No comment yet
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
thoughtful Bat_8163 : i have noticed this company 6 years ago as it merges with Progenics, one of my holdings. Amazing development!